Abstract:Background: Roux-en-Y gastric bypass (RYGB) has been proved to be more effective than other bariatric procedures in the long term on body-weight loss and remission of diabetes. However, the mechanism remains poorly understood. Long-term changes in energy metabolism after RYGB have rarely been reported. Objective: To investigate the long-term effects of RYGB on energy metabolism on a dietinduced obesity (DIO) mouse model. Methods: DIO mice fed a high-fat diet were assigned to two groups: RYGB (n=8) and sham (n=7), followed by high-fat diet feeding until 12 weeks after surgery. Body weight and food intake were recorded weekly. Measurement of body composition and energy metabolism by metabolic chamber were conducted at weeks 4, 8, and 12 after surgery. Fecal energy measurement, intraperitoneal glucose-tolerance tests, and insulin-tolerance tests were conducted at postoperative week 12. Results: Food intake was reduced in the RYGB group within the first 3 weeks after surgery and increased to the same as the sham group from postoperative week 4. At 12 weeks after surgery, body weight had reduced by 36%+/- 3.2% in the RYGB group compared to a 16%+/- 2% body-weight gain in the sham group, while fat mass had reduced significantly in the RYGB group compared to the sham group (9.2%+/- 1.5% versus 30.1%+/- 0.7%). Energy expenditure was significantly higher at postoperative week 8 in the RYGB group than the sham group. In comparison with the sham group, the respiratory exchange ratio was unchanged, decreased, and increased in the RYGB group at postoperative weeks 4, 8, and 12, respectively. Fecal energy measurement showed that feces from mice in the RYGB group contained higher energy levels than the sham group. Glucose metabolism had significantly improved in the RYGB group, in contrast to the sham group, demonstrated by intraperitoneal glucose tolerance tests (AUC 1,502 +/- 104 versus 2,277 +/- 198, respectively) and insulin tolerance tests (AUC 524 +/- 50 versus 838 +/- 63, respectively). Conclusion: Increased energy expenditure and energy loss through feces contribute to long-term body-weight control after RYGB. Enhanced glucose utilization might play a role in long-term improvement in glucose metabolism.

Leptin Deficient Ob/ob Mice and Diet-Induced Obese Mice Responded Differently to Roux-en-Y Bypass Surgery

Leptin receptor deficiency impedes metabolic surgery related-weight loss through inhibition of energy expenditure in db/db mice

Increased Energy Expenditure and Energy Loss Through Feces Contribute to the Long-Term Outcome of Roux-en-Y Gastric Bypass in a Diet-Induced Obese Mouse Model

Reprogramming of Defended Body Weight after Roux-En-Y Gastric Bypass Surgery in Diet-Induced Obese Mice

Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice

Unlike calorie restriction, Roux-en-Y gastric bypass surgery does not increase hypothalamic AgRP and NPY in mice on a high-fat diet

GLP-1 Receptor Signaling is Not Required for Reduced Body Weight after RYGB in Rodents.

Gastric Inhibitory Polypeptide (GIP) is Selectively Decreased in the Roux-Limb of Dietary Obese Mice after RYGB Surgery

RYGB Is More Effective than VSG at Protecting Mice from Prolonged High-Fat Diet Exposure: An Occasion to Roll Up Our Sleeves?

Changes of Serum Lipopolysaccharide, Inflammatory Factors, and Cecal Microbiota in Obese Rats with Type 2 Diabetes Induced by Roux-en-Y Gastric Bypass

Roux-en-Y Gastric Bypass Improved Insulin Resistance Via Alteration of the Human Gut Microbiome and Alleviation of Endotoxemia

Development and Verification of a Mouse Model for Roux-en-Y Gastric Bypass Surgery with a Small Gastric Pouch

Roux-en-Y Gastric Bypass Compared to Equivalent Diet Restriction: Mechanistic Insights into Diabetes Remission.

Eating in Mice with Gastric Bypass Surgery Causes Exaggerated Activation of Brainstem Anorexia Circuit

Gastric bypass surgery is protective from high-fat diet-induced non-alcoholic fatty liver disease and hepatic endoplasmic reticulum stress

Lower ghrelin levels does not impact the metabolic benefit induced by Roux-en-Y gastric bypass

Body Composition, Food Intake, and Energy Expenditure in a Murine Model of Roux-en-Y Gastric Bypass Surgery.

Roux-en-Y gastric bypass potentially improved intestinal permeability by regulating gut innate immunity in diet-induced obese mice

Decreased Leptin Is Associated With Alterations In Thyroid-Stimulating Hormone Levels After Roux-En-Y Gastric Bypass Surgery In Obese Euthyroid Patients With Type 2 Diabetes

Gastric bypass and banding equally improve insulin sensitivity and β cell function.